Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Greenwich Lifesciences Inc
(NQ:
GLSI
)
13.85
+0.14 (+1.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Greenwich Lifesciences Inc
< Previous
1
2
Next >
Greenwich LifeSciences to Participate in Citi’s 16th Annual Biopharma Virtual Conference
September 07, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Set to Join Russell 2000® Index
June 08, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ASCO 2021, Confirming that GP2 Treatment to Prevent Metastatic Breast Cancer Recurrence is Well Tolerated
June 07, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Announces Update of GP2 Phase III Clinical Trial Design at the 2021 AACR Annual Meeting
April 14, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
April 12, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
April 10, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-up
April 09, 2021
From
Greenwich LifeSciences, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.